Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized Trials

Background. In metastatic colorectal cancer (mCRC), continuing antiangiogenic drugs beyond progression might provide clinical benefit. We synthesized the available evidence in a meta-analysis. Patients and Methods. We conducted a meta-analysis of studies investigating the use of antiangiogenic drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofheinz, R.-D., Ronellenfitsch, U., Kubicka, S., Falcone, A., Burkholder, I., Hacker, U. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021498/
https://www.ncbi.nlm.nih.gov/pubmed/27656206
http://dx.doi.org/10.1155/2016/9189483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021498/
https://www.ncbi.nlm.nih.gov/pubmed/27656206
http://dx.doi.org/10.1155/2016/9189483

Ejemplares similares